GSK vs TSE · P/E 13, $103.31B cap vs rev $3.51B
GlaxoSmithKline PLC ADR (GSK) versus Trinseo SA (TSE) — a side-by-side from cached financials, not a winner call.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Trinseo SA (TSE) is a specialty chemicals company listed on NYSE.
GSK does not have a complete income-statement cache yet.
Latest reported TSE revenue for 2024-12-31 was $3.51B. Net income was -$348.5M. Revenue was down 4.4% from 2023-12-31 to 2024-12-31. TSE currently screens at market cap $8.3M.
GSK currently screens at market cap $103.31B and trailing P/E 13.5. TSE currently screens at market cap $8.3M.
Not investment advice. Open the GSK and TSE stock pages for the full models.
Not investment advice.